Precision Medicine Market Growing around US$ 84 Bn by 2027
As per the research held by Acumen Research and Consulting, βthe global Precision Medicine market anticipated to exceed US$ 84 Bn by 2027, along with the projected CAGR of 10% from 2020 to 2027β.
The global Precision Medicine market research report encompasses qualitative and quantitative data derived from the analysis by experts and research analysts in the respective industry verticals from valid sources with the help of primary and secondary research tools.
Get Sample PDF @ https://www.acumenresearchandconsulting.com/request-sample/1588
The major market factors which are driving, hindering, challenging, or providing opportunities are specifically covered to better understand the market position, Recent market trends and governmental regulation & standards are additionally incorporated.
The research report has majorly profiled market information, DROs, segmentation, regional instance, and competitive landscape. The aforementioned entities further encompass prominent sections according to the need of the respective market. Moreover, regional segmentation includes North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and their respective major countries. The dipper information is profiled in terms of regions for getting recent and expected trends and opportunities in the regional market.
Furthermore, in terms of prominent players, the research report comprises a number of major players that are operating in the global competitive environment and offering advance and value-added products to the consumers. A detailed analysis is executed on these players in terms of the business snapshot, product offerings, financial overview, strategic development, player positioning, and R&D investment. This information is essential for the competitors and those who are planning to enter the market.
In a nutshell, the research report is a completely designed solution for those who are seeking information and available opportunities to take decisions of expansion in the desired market. As well as, the research report is also a value-added solution of the research students to get more specific information associated with the market.
Market participants
Tepnel Pharma Services, Novartis, Qiagen, Biocrates Life Sciences, NanoString Technologies, Roche, Pfizer, Eagle Genomics, Quest Diagnostics, Menarini Silicon Biosystems, Intomics, and Teva Pharmaceutical and Others.
Market segmentation
Precision Medicine Market By Technology
- Big Data Analytics
- Bioinformatics
- Gene Sequencing
- Drug Discovery
- Companion Diagnostics
- Others
Precision Medicine Market By Application
- Oncology
- Immunology
- CNS
- Respiratory
Precision Medicine Market By End Use
- Home care
- Hospitals
- Clinical Laboratories
- Others
Precision Medicine Market By Geography
- North America
- US.
- Canada
- Europe
- UK
- Germany
- France
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- GCC
- South Africa
- Rest of MEA
Table of content
CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Hydraulic Fracturing
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Precision Medicine Market By Technology
1.2.2.1. Global Precision Medicine Market Revenue and Growth Rate Comparison By Technology (2015-2026)
1.2.2.2. Global Precision Medicine Market Revenue Share By Technology in 2018
1.2.2.3. Big Data Analytics
1.2.2.4. Bioinformatics
1.2.2.5. Gene Sequencing
1.2.2.6. Drug Discovery
1.2.2.7. Companion Diagnostics
1.2.2.8. Others
1.2.3. Precision Medicine Market By Application
1.2.3.1. Global Precision Medicine Market Revenue and Growth Rate Comparison By Application (2015-2026)
1.2.3.2. Oncology
1.2.3.3. Immunology
1.2.3.4. CNS
1.2.3.5. Respiratory
1.2.4. Precision Medicine Market By End Use
1.2.4.1. Global Precision Medicine Market Revenue and Growth Rate Comparison By Application (2015-2026)
1.2.4.2. Home care
1.2.4.3. Hospitals
1.2.4.4. CBM
1.2.4.5. Clinical Laboratories
1.2.4.6. Others
1.2.5. Precision Medicine Market By Geography
1.2.5.1. Global Precision Medicine Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.5.2. North AmericaPrecision Medicine Market Revenue and Growth Rate(2015-2026)
1.2.5.3. EuropePrecision Medicine Market Revenue and Growth Rate(2015-2026)
1.2.5.4. Asia-PacificPrecision Medicine Market Revenue and Growth Rate(2015-2026)
1.2.5.5. Latin AmericaPrecision Medicine Market Revenue and Growth Rate(2015-2026)
1.2.5.6. Middle East and Africa (MEA)Precision Medicine Market Revenueand Growth Rate(2015-2026)
CHAPTER 2. MARKET DYNAMICSAND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porterβs Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2018
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players
CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Hydraulic Fracturing Major Manufacturers in 2018
3.2. Manufacturing Plants Distribution of Global Hydraulic Fracturing Major Manufacturers in 2018
3.3. R&D Status and Technology Source of Global Hydraulic Fracturing Major Manufacturers in 2018
3.4. Raw Materials Sources Analysis of Global Hydraulic Fracturing Major Manufacturers in 2018
CHAPTER 4. PRECISION MEDICINE MARKET BY TECHNOLOGY
4.1. Global Hydraulic Fracturing Revenue By Technology
4.2. Big Data Analytics
4.2.1. Market Revenue and Growth Rate, 2015 β 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 β 2026 ($Million)
4.3. Bioinformatics
4.3.1. Market Revenue and Growth Rate, 2015 β 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 β 2026 ($Million)
4.4. Gene Sequencing
4.4.1. Market Revenue and Growth Rate, 2015 β 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 β 2026 ($Million)
4.5. Drug Discovery
4.5.1. Market Revenue and Growth Rate, 2015 β 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 β 2026 ($Million)
4.6. Companion Diagnostics
4.6.1. Market Revenue and Growth Rate, 2015 β 2026 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2015 β 2026 ($Million)
4.7. Others
4.7.1. Market Revenue and Growth Rate, 2015 β 2026 ($Million)
4.7.2. Market Revenue and Forecast, By Region, 2015 β 2026 ($Million)
CHAPTER 5. PRECISION MEDICINE MARKET BY APPLICATION
5.1. Global Hydraulic Fracturing Revenue By Application
5.2. Oncology
5.2.1. Market Revenue and Growth Rate, 2015 β 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 β 2026 ($Million)
5.3. Immunology
5.3.1. Market Revenue and Growth Rate, 2015 β 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 β 2026 ($Million)
5.4. CNS
5.4.1. Market Revenue and Growth Rate, 2015 β 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 β 2026 ($Million)
5.5. Respiratory
5.5.1. Market Revenue and Growth Rate, 2015 β 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 β 2026 ($Million)
CHAPTER 6. PRECISION MEDICINE MARKET By End Use
6.1. Global Hydraulic Fracturing Revenue By End Use
6.2. Home care
6.2.1. Market Revenue and Growth Rate, 2015 β 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 β 2026 ($Million)
6.3. Hospitals
6.3.1. Market Revenue and Growth Rate, 2015 β 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 β 2026 ($Million)
6.4. Clinical Laboratories
6.4.1. Market Revenue and Growth Rate, 2015 β 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 β 2026 ($Million)
6.5. Others
6.5.1. Market Revenue and Growth Rate, 2015 β 2026 ($Million)
6.5.2. Market Revenue and Forecast, By Region, 2015 β 2026 ($Million)
CHAPTER 7. NORTH AMERICA PRECISION MEDICINE MARKET BY COUNTRY
7.1. North America Precision Medicine Market Revenue and Growth Rate, 2015 β 2026 ($Million)
7.2. North America Precision Medicine Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
7.3.1. U.S. Precision Medicine Market Revenue and Forecast By Technology, 2015 β 2026 ($Million)
7.3.2. Market Revenue and Forecast By Application, 2015 β 2026 ($Million)
7.3.3. Market Revenue and Forecast By End Use, 2015 β 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Technology, 2015 β 2026 ($Million)
7.4.2. Market Revenue and Forecast By Application, 2015 β 2026 ($Million)
7.4.3. Market Revenue and Forecast By End Use, 2015 β 2026 ($Million)
CHAPTER 8. EUROPE PRECISION MEDICINE MARKET BY COUNTRY
8.1. Europe Precision Medicine Market Revenue and Growth Rate, 2015 β 2026 ($Million)
8.2. Europe Precision Medicine Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Technology, 2015 β 2026 ($Million)
8.3.2. Market Revenue and Forecast By Application, 2015 β 2026 ($Million)
8.3.3. Market Revenue and Forecast By End Use, 2015 β 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Technology, 2015 β 2026 ($Million)
8.4.2. Market Revenue and Forecast By Application, 2015 β 2026 ($Million)
8.4.3. Market Revenue and Forecast By End Use, 2015 β 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Technology, 2015 β 2026 ($Million)
8.5.2. Market Revenue and Forecast By Application, 2015 β 2026 ($Million)
8.5.3. Market Revenue and Forecast By End Use, 2015 β 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Technology, 2015 β 2026 ($Million)
8.6.2. Market Revenue and Forecast By Application, 2015 β 2026 ($Million)
8.6.3. Market Revenue and Forecast By End Use, 2015 β 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Technology, 2015 β 2026 ($Million)
8.7.2. Market Revenue and Forecast By Application, 2015 β 2026 ($Million)
8.7.3. Market Revenue and Forecast By End Use, 2015 β 2026 ($Million)
CHAPTER 9. ASIA-PACIFIC PRECISION MEDICINE MARKET BY COUNTRY
9.1. Asia-Pacific Precision Medicine Market Revenue and Growth Rate, 2015 β 2026 ($Million)
9.2. Asia-Pacific Precision Medicine Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Technology, 2015 β 2026 ($Million)
9.3.2. Market Revenue and Forecast By Application, 2015 β 2026 ($Million)
9.3.3. Market Revenue and Forecast By End Use, 2015 β 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Technology, 2015 β 2026 ($Million)
9.4.2. Market Revenue and Forecast By Application, 2015 β 2026 ($Million)
9.4.3. Market Revenue and Forecast By End Use, 2015 β 2026 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Technology, 2015 β 2026 ($Million)
9.5.2. Market Revenue and Forecast By Application, 2015 β 2026 ($Million)
9.5.3. Market Revenue and Forecast By End Use, 2015 β 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Technology, 2015 β 2026 ($Million)
9.6.2. Market Revenue and Forecast By Application, 2015 β 2026 ($Million)
9.6.3. Market Revenue and Forecast By End Use, 2015 β 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Technology, 2015 β 2026 ($Million)
9.7.2. Market Revenue and Forecast By Application, 2015 β 2026 ($Million)
9.7.3. Market Revenue and Forecast By End Use, 2015 β 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Technology, 2015 β 2026 ($Million)
9.8.2. Market Revenue and Forecast By Application, 2015 β 2026 ($Million)
9.8.3. Market Revenue and Forecast By End Use, 2015 β 2026 ($Million)
CHAPTER 10. LATIN AMERICA PRECISION MEDICINE MARKET BY COUNTRY
10.1. Latin America Precision Medicine Market Revenue and Growth Rate, 2015 β 2026 ($Million)
10.2. Latin America Precision Medicine Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Technology, 2015 β 2026 ($Million)
10.3.2. Market Revenue and Forecast By Application, 2015 β 2026 ($Million)
10.3.3. Market Revenue and Forecast By End Use, 2015 β 2026 ($Million)
10.4. Mexico
10.4.1. Market Revenue and Forecast By Technology, 2015 β 2026 ($Million)
10.4.2. Market Revenue and Forecast By Application, 2015 β 2026 ($Million)
10.4.3. Market Revenue and Forecast By End Use, 2015 β 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Technology, 2015 β 2026 ($Million)
10.5.2. Market Revenue and Forecast By Application, 2015 β 2026 ($Million)
10.5.3. Market Revenue and Forecast By End Use, 2015 β 2026 ($Million)
CHAPTER 11. MIDDLE EAST & AFRICA PRECISION MEDICINE MARKET BY COUNTRY
11.1. Middle East & Africa Precision Medicine Market Revenue and Growth Rate, 2015 β 2026 ($Million)
11.2. Middle East & Africa Precision Medicine Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. GCC
11.3.1. Market Revenue and Forecast By Technology, 2015 β 2026 ($Million)
11.3.2. Market Revenue and Forecast By Application, 2015 β 2026 ($Million)
11.3.3. Market Revenue and Forecast By End Use, 2015 β 2026 ($Million)
11.4. South Africa
11.4.1. Market Revenue and Forecast By Technology, 2015 β 2026 ($Million)
11.4.2. Market Revenue and Forecast By Application, 2015 β 2026 ($Million)
11.4.3. Market Revenue and Forecast By End Use, 2015 β 2026 ($Million)
11.5. Rest of Middle East & Africa
11.5.1. Market Revenue and Forecast By Technology, 2015 β 2026 ($Million)
11.5.2. Market Revenue and Forecast By Application, 2015 β 2026 ($Million)
11.5.3. Market Revenue and Forecast By End Use, 2015 β 2026 ($Million)
CHAPTER 12. COMPANY PROFILE
12.1. Tepnel Pharma Services
12.1.1. Company Snapshot
12.1.2. Overview
12.1.3. Financial Overview
12.1.4. Type Portfolio
12.1.5. Key Developments
12.1.6. Strategies
12.2. Novartis
12.2.1. Company Snapshot
12.2.2. Overview
12.2.3. Financial Overview
12.2.4. Type Portfolio
12.2.5. Key Developments
12.2.6. Strategies
12.3. Qiagen
12.3.1. Company Snapshot
12.3.2. Overview
12.3.3. Financial Overview
12.3.4. Type Portfolio
12.3.5. Key Developments
12.3.6. Strategies
12.4. Biocrates Life Sciences
12.4.1. Company Snapshot
12.4.2. Overview
12.4.3. Financial Overview
12.4.4. Type Portfolio
12.4.5. Key Developments
12.4.6. Strategies
12.5. NanoString Technologies
12.5.1. Company Snapshot
12.5.2. Overview
12.5.3. Financial Overview
12.5.4. Type Portfolio
12.5.5. Key Developments
12.5.6. Strategies
12.6. Roche
12.6.1. Company Snapshot
12.6.2. Overview
12.6.3. Financial Overview
12.6.4. Type Portfolio
12.6.5. Key Developments
12.6.6. Strategies
12.7. Pfizer
12.7.1. Company Snapshot
12.7.2. Overview
12.7.3. Financial Overview
12.7.4. Type Portfolio
12.7.5. Key Developments
12.7.6. Strategies
12.8. Eagle Genomics
12.8.1. Company Snapshot
12.8.2. Overview
12.8.3. Financial Overview
12.8.4. Type Portfolio
12.8.5. Key Developments
12.8.6. Strategies
12.9. Quest Diagnostics
12.9.1. Company Snapshot
12.9.2. Overview
12.9.3. Financial Overview
12.9.4. Type Portfolio
12.9.5. Key Developments
12.9.6. Strategies
12.10. Menarini Silicon Biosystems
12.10.1. Company Snapshot
12.10.2. Overview
12.10.3. Financial Overview
12.10.4. Type Portfolio
12.10.5. Key Developments
12.10.6. Strategies
12.11. Intomics
12.11.1. Company Snapshot
12.11.2. Overview
12.11.3. Financial Overview
12.11.4. Type Portfolio
12.11.5. Key Developments
12.11.6. Strategies
12.12. Teva Pharmaceutical
12.12.1. Company Snapshot
12.12.2. Overview
12.12.3. Financial Overview
12.12.4. Type Portfolio
12.12.5. Key Developments
12.12.6. Strategies
12.13. Others
12.13.1. Company Snapshot
12.13.2. Overview
12.13.3. Financial Overview
12.13.4. Type Portfolio
12.13.5. Key Developments
12.13.6. Strategies
CHAPTER 13. RESEARCH APPROACH
13.1. Research Methodology
13.1.1. Initial Data Search
13.1.2. Secondary Research
13.1.3. Primary Research
13.2. Assumptions and Scope
Buy this premium report @ https://www.acumenresearchandconsulting.com/buy-now/0/1588
Contact us:
Sheetal k
Email: sales@acumenresearchandconsulting.com
Phone: +14079154157 | +14089009135